PO.BCS01.02 · 生物信息与计算
Bulk RNA-seq atlas guided annotation of tumor transcriptomes
作者与单位
摘要 Abstract
Single-cell RNA sequencing (scRNA-seq) enables high-resolution profiling of cellular heterogeneity, revealing novel transcriptomic states. However, many existing generative and foundational single-cell models are trained predominantly on non-neoplastic data, limiting their accuracy in cancer cell annotation. We present SPOTTER (Seed-guided Prediction Of Tumor Transcriptomes with Ensemble Recognition), a framework that integrates bulk RNA sequencing (bulk RNA-seq) cancer atlases with single-cell data. SPOTTER first classifies individual cells using an ensemble neural network classifier OTTER (Oncologic TranscripTome Expression Recognition), trained on the hierarchical RACCOON (Resolution-Adaptive Coarse-to-fine Clusters OptimizatiON) cancer atlas spanning over 15,000 pediatric and adult cancer samples. High-confidence seed labels are selected using a Gaussian mixture model (GMM) and Gini impurity-based filtering of OTTER scores to exclude low-quality cells with uncertain predictions. These labels are then propagated through scANVI (single-cell Annotation using Variational Inference) to achieve per-cell classifications. Across nine diverse pediatric and adult single-cell and single-nucleus cancer datasets, SPOTTER reliably assigned malignant cells to their expected tumor classes. In Ewing sarcoma samples with matched bulk RNA-seq and single-nucleus RNA-seq (snRNA-seq), SPOTTER recapitulated bulk RNA-seq-defined subtypes at single-cell resolution, distinguishing one subtype enriched for neuronal programs, including SYT1 and SOX6 , and another with increased EWS-FLI1 fusion activity and elevated JAK1 signaling-consistent with subtypes previously identified by OTTER and RACCOON in bulk RNA-seq. By integrating bulk and single-cell analyses, SPOTTER enables characterization of tumor heterogeneity and supports identification of subtype-specific markers to reveal critical insights into the transcriptomic profile of a cancer.
利益披露 Disclosure
T. T. Wen, None..
D. Pesic, None..
P. L. Ballester, None..
J. Nash, None.
A. Shlien,
NewCode Oncology Stock, Patent, Patents filed on RACCOON/OTTER algorithm are licensed to NewCode Oncology. AS is a co-founder of NewCode Oncology.